Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Silpak Biswas, Jean-Michel Brunel, Jean-Christophe Dubus, Martine Reynaud-Gaubert & Jean-Marc Rolain. (2012) Colistin: an update on the antibiotic of the 21st century. Expert Review of Anti-infective Therapy 10:8, pages 917-934.
Read now
Read now
Mao Hagihara, Jared L Crandon & David P Nicolau. (2012) The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms. Expert Opinion on Drug Safety 11:2, pages 221-233.
Read now
Read now
Marco Cassone & Laszlo Otvos Jr. (2010) Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Review of Anti-infective Therapy 8:6, pages 703-716.
Read now
Read now
David Felipe Briceño, John P Quinn & María Virginia Villegas. (2010) Treatment options for multidrug-resistant nonfermenters. Expert Review of Anti-infective Therapy 8:3, pages 303-315.
Read now
Read now
K.C. Guelfi, M.C.B. Tognim, C.L. Cardoso, A.C. Gales, F.E. Carrara-Marrone & L.B. Garcia. (2008)
In Vitro Evaluation of the Antimicrobial Activity of Meropenem in Combination with Polymyxin B and Gatifloxacin Against Pseudomonas aeruginosa and Acinetobacter baumannii
. Journal of Chemotherapy 20:2, pages 180-185.
Read now
Read now
Paolo Grossi & Daniela Dalla Gasperina. (2006) Treatment of Pseudomonas aeruginosa infection in critically ill patients. Expert Review of Anti-infective Therapy 4:4, pages 639-662.
Read now
Read now
Kazuhiro Tateda, Yoshikazu Ishii, Tetsuya Matsumoto & Keizo Yamaguchi. (2006) ‘Break-point Checkerboard Plate’ for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Scandinavian Journal of Infectious Diseases 38:4, pages 268-272.
Read now
Read now
Articles from other publishers (46)
Eva Armengol, Kasper Nørskov Kragh, Tim Tolker-Nielsen, Josep M. Sierra, Doaa Higazy, Oana Ciofu, Miguel Viñas & Niels Høiby. (2023) Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms. Antimicrobial Agents and Chemotherapy 67:4.
Crossref
Crossref
Zhangyong Si, Kevin Pethe & Mary B. Chan-Park. (2023) Chemical Basis of Combination Therapy to Combat Antibiotic Resistance. JACS Au 3:2, pages 276-292.
Crossref
Crossref
Yiyun Zhu, Weijing Hao, Xia Wang, Jianhong Ouyang, Xinyi Deng, Haining Yu & Yipeng Wang. (2022) Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections. Medicinal Research Reviews 42:4, pages 1377-1422.
Crossref
Crossref
Zhaofei Guo, Yining Zhu, Guangsheng Du, Ming Qin, Chunting He, Penghui He, Yuanshuai Song, Wenfei Chen, Shuting Bai, Fuhua Wu, Nan Qiao, Min Jiang, Xianjin Luo, Yuandong Zhang, Tao Gong, Zhirong Zhang & Xun Sun. (2022) Rapid development of a subunit nano-vaccine against drug-resistant Pseudomonas aeruginosa with effective cross-protection. Nano Today 43, pages 101398.
Crossref
Crossref
Song Oh, Raymond Chau, Anh T. Nguyen & Justin R. Lenhard. (2021) Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?. Antibiotics 10:6, pages 646.
Crossref
Crossref
Luigia Scudeller, Elda Righi, Margherita Chiamenti, Damiano Bragantini, Giulia Menchinelli, Paolo Cattaneo, Christian G. Giske, Thomas Lodise, Maurizio Sanguinetti, Laura J.V. Piddock, François Franceschi, Sally Ellis, Elena Carrara, Alessia Savoldi & Evelina Tacconelli. (2021) Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International Journal of Antimicrobial Agents 57:5, pages 106344.
Crossref
Crossref
Sue C. Nang, Mohammad A. K. Azad, Tony Velkov, Qi (Tony) Zhou & Jian Li. (2021) Rescuing the Last-Line Polymyxins: Achievements and Challenges. Pharmacological Reviews 73:2, pages 679-728.
Crossref
Crossref
Shanti Narayanasamy, Roger L Nation, Andrew A Mahony, M Lindsay Grayson, Jason C Kwong, Norelle L Sherry, Sharmila Khumra, Andrew G Ellis, Albert G Frauman & Natasha E Holmes. (2021)
Cure of Limb-Threatening XDR
Pseudomonas aeruginosa
Infection: Combining Genome Sequencing, Therapeutic Drug Level Monitoring, and Surgical Debridement
. Open Forum Infectious Diseases 8:1.
Crossref
Crossref
Jie Liu, Fangyi Chen, Xiaofei Wang, Hui Peng, Hua Zhang & Ke-Jian Wang. (2020) The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph12−38 With Antibiotics Azithromycin and Rifampicin Enhances Bactericidal Activity Against Pseudomonas Aeruginosa. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Stephanie Portelli, Yoochan Myung, Nicholas Furnham, Sundeep Chaitanya Vedithi, Douglas E. V. Pires & David B. Ascher. (2020) Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches. Scientific Reports 10:1.
Crossref
Crossref
Narongsak Nakwan, Kulkanya Chokephaibulkit & Roberto Imberti. (2019) The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants. Pediatric Infectious Disease Journal 38:11, pages 1107-1112.
Crossref
Crossref
Julio César García, Henry Robayo Amortegui & Adriana Carrasco Márquez. (2019) Multirresistencia de Acinetobacter baumannii: revisión narrativa. Acta Colombiana de Cuidado Intensivo 19:4, pages 219-226.
Crossref
Crossref
Konstantinos Z. Vardakas, Florentia Athanassaki, Vassiliki Pitiriga & Matthew E. Falagas. (2019) Clinical relevance of in vitro synergistic activity of antibiotics for multidrug-resistant Gram-negative infections: A systematic review. Journal of Global Antimicrobial Resistance 17, pages 250-259.
Crossref
Crossref
Phillip J. Bergen, Nicholas M. Smith, Tyler B. Bedard, Zackery P. Bulman, Raymond Cha & Brian T. Tsuji. 2019. Polymyxin Antibiotics: From Laboratory Bench to Bedside. Polymyxin Antibiotics: From Laboratory Bench to Bedside
251
288
.
Dror Marchaim, Donald Kaye & Keith S. Kaye. 2019. Polymyxin Antibiotics: From Laboratory Bench to Bedside. Polymyxin Antibiotics: From Laboratory Bench to Bedside
155
179
.
Yun Cai, Deqing Yang, Jin Wang & Rui Wang. (2018) Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model. Journal of Antimicrobial Chemotherapy 73:2, pages 456-461.
Crossref
Crossref
Francesc Rabanal & Yolanda Cajal. (2017) Recent advances and perspectives in the design and development of polymyxins. Natural Product Reports 34:7, pages 886-908.
Crossref
Crossref
Ryan P Lamers & Lori L Burrows. (2016)
Pseudomonas aeruginosa
: targeting cell-wall metabolism for new antibacterial discovery and development
. Future Medicinal Chemistry 8:9, pages 975-992.
Crossref
Crossref
Hyukmin Lee, Kyung Ho Roh, Seong Geun Hong, Hee Bong Shin, Seok Hoon Jeong, Wonkeun Song, Young Uh, Dongeun Yong & Kyungwon Lee. (2016)
In Vitro
Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant
Pseudomonas aeruginosa
and
Acinetobacter baumannii
Isolates
. Annals of Laboratory Medicine 36:2, pages 138-144.
Crossref
Crossref
J. Daniel Markley, Shaina Bernard & Oveimar Delacruz. (2015) Combination Antibiotic Therapy for the Definitive Management of Select Multidrug-Resistant Gram-Negative Rod Infections. Current Treatment Options in Infectious Diseases 7:4, pages 273-290.
Crossref
Crossref
Phillip J. Bergen, Zackery P. Bulman, Cornelia B. Landersdorfer, Nicholas Smith, Justin R. Lenhard, Jürgen B. Bulitta, Roger L. Nation, Jian Li & Brian T. Tsuji. (2015) Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria. Infectious Diseases and Therapy 4:4, pages 391-415.
Crossref
Crossref
Kazunori Kadota, Takuro Nishimura, Daiki Hotta & Yuichi Tozuka. (2015) Preparation of composite particles of hydrophilic or hydrophobic drugs with highly branched cyclic dextrin via spray drying for dry powder inhalers. Powder Technology 283, pages 16-23.
Crossref
Crossref
Yang Peng, Jing Shi, Tao Bu, Ying Li, Xiaohua Ye, Xiaofeng Chen & Zhenjiang Yao. (2015) Alarming and increasing prevalence of multidrug-resistant Pseudomonas aeruginosa among healthcare-associated infections in China: A meta-analysis of cross-sectional studies. Journal of Global Antimicrobial Resistance 3:3, pages 155-160.
Crossref
Crossref
Jun-Jie Koh, Huifen Lin, Vonny Caroline, Yu Siang Chew, Li Mei Pang, Thet Tun Aung, Jianguo Li, Rajamani Lakshminarayanan, Donald T. H. Tan, Chandra Verma, Ai Ling Tan, Roger W. Beuerman & Shouping Liu. (2015) N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization. Journal of Medicinal Chemistry 58:16, pages 6533-6548.
Crossref
Crossref
O. Bargiacchi, A. Rossati, P. Car, D. Brustia, R. Brondolo, F. Rosa, P. L. Garavelli & F. G. De Rosa. (2014) Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review. Infection 42:5, pages 801-809.
Crossref
Crossref
Nihal Martis, Sylvie Leroy & V?ronique Blanc. (2014) Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections. Journal of Infection 69:1, pages 1-12.
Crossref
Crossref
Carlo Tascini, Enrico Tagliaferri, Tommaso Giani, Alessandro Leonildi, Sarah Flammini, Beatrice Casini, Russell Lewis, Simone Ferranti, Gian Maria Rossolini & Francesco Menichetti. (2013) Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 57:8, pages 3990-3993.
Crossref
Crossref
R. Imberti, M. Regazzi & G. A. Iotti. 2013. Annual Update in Intensive Care and Emergency Medicine 2013. Annual Update in Intensive Care and Emergency Medicine 2013
99
110
.
É. Kipnis & B.-P. Guery. (2010) Réévaluation de la colistine. Antibiotiques 12:4, pages 205-227.
Crossref
Crossref
Michele J. Anderson, Mary E. Horn, Ying-Chi Lin, Patrick J. Parks & Marnie L. Peterson. (2010) Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. American Journal of Infection Control 38:10, pages 826-831.
Crossref
Crossref
C.M.J. Drapeau, E. Grilli & N. Petrosillo. (2010) Rifampicin combined regimens for Gram-negative infections: data from the literature. International Journal of Antimicrobial Agents 35:1, pages 39-44.
Crossref
Crossref
Luigi Principe, Silvia D'Arezzo, Alessandro Capone, Nicola Petrosillo & Paolo Visca. (2009) In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Annals of Clinical Microbiology and Antimicrobials 8:1.
Crossref
Crossref
A. A. El Solh & A. Alhajhusain. (2009) Update on the treatment of Pseudomonas aeruginosa pneumonia. Journal of Antimicrobial Chemotherapy 64:2, pages 229-238.
Crossref
Crossref
N. Aoki, K. Tateda, Y. Kikuchi, S. Kimura, C. Miyazaki, Y. Ishii, Y. Tanabe, F. Gejyo & K. Yamaguchi. (2009) Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 63:3, pages 534-542.
Crossref
Crossref
N. Petrosillo, E. Ioannidou & M.E. Falagas. (2008) Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clinical Microbiology and Infection 14:9, pages 816-827.
Crossref
Crossref
David Landman, Claudiu Georgescu, Don Antonio Martin & John Quale. (2008) Polymyxins Revisited. Clinical Microbiology Reviews 21:3, pages 449-465.
Crossref
Crossref
Sohini Sarkar, Evelyn R. Hermes DeSantis & Jeff Kuper. (2007) Resurgence of colistin use. American Journal of Health-System Pharmacy 64:23, pages 2462-2466.
Crossref
Crossref
Guilherme Henrique Campos Furtado, Pedro Alves d’Azevedo, Anderson Fernandes Santos, Ana Cristina Gales, Antônio Carlos Campos Pignatari & Eduardo Alexandrino Servolo Medeiros. (2007) Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 30:4, pages 315-319.
Crossref
Crossref
Ray Y. Hachem, Roy F. Chemaly, Corine A. Ahmar, Ying Jiang, Maha R. Boktour, Georges Abou Rjaili, Gerald P. Bodey & Issam I. Raad. (2007)
Colistin Is Effective in Treatment of Infections Caused by Multidrug-Resistant
Pseudomonas aeruginosa
in Cancer Patients
. Antimicrobial Agents and Chemotherapy 51:6, pages 1905-1911.
Crossref
Crossref
Tamra M. Arnold, Graeme N. Forrest & Karen J. Messmer. (2007) Polymyxin antibiotics for gram-negative infections. American Journal of Health-System Pharmacy 64:8, pages 819-826.
Crossref
Crossref
M.E. Falagas, P.I. Rafailidis, S.K. Kasiakou, P. Hatzopoulou & A. Michalopoulos. (2006) Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin–meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clinical Microbiology and Infection 12:12, pages 1227-1230.
Crossref
Crossref
Matthew E. Falagas, Patra K. Koletsi & Ioannis A. Bliziotis. (2006) The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Journal of Medical Microbiology 55:12, pages 1619-1629.
Crossref
Crossref
Carlo Tascini, F. Menichetti, G. Gemignani, F. Palumbo, A. Leonildi, A. Tedeschi & A. Piaggesi. (2016) Clinical and Microbiological Efficacy of Colistin Therapy in Combination With Rifampin and Imipenem in Multidrug-Resistant Pseudomonas aeruginosa Diabetic Foot Infection With Osteomyelitis. The International Journal of Lower Extremity Wounds 5:3, pages 213-216.
Crossref
Crossref
Marilee D. Obritsch, Douglas N. Fish, Robert MacLaren & Rose Jung. (2005)
Nosocomial Infections Due to Multidrug-Resistant
Pseudomonas aeruginosa
: Epidemiology and Treatment Options
. Pharmacotherapy 25:10, pages 1353-1364.
Crossref
Crossref
Shiri Navon-Venezia, Ronen Ben-Ami & Yehuda Carmeli. (2005) Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Current Opinion in Infectious Diseases 18:4, pages 306-313.
Crossref
Crossref
M. E. Falagas, S. K. Kasiakou & L. D. Saravolatz. (2005) Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections. Clinical Infectious Diseases 40:9, pages 1333-1341.
Crossref
Crossref